相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YAP Promotes Migration and Invasion of Human Glioma Cells
Yu Zhang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma
Damir Nizamutdinov et al.
WORLD NEUROSURGERY (2018)
Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer
Hsiang-Hsi Ling et al.
EXPERIMENTAL CELL RESEARCH (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
Venkata Ramesh Dasari et al.
ONCOTARGET (2017)
Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
Eleni K. Konstantinou et al.
SCIENTIFIC REPORTS (2017)
Verteporfin inhibits growth of human glioma in vitro without light activation
Ahmad Al-Moujahed et al.
SCIENTIFIC REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics
Danuta S. Kalinowski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Expression and significance of Hippo/YAP signaling in glioma progression
Hao Zhang et al.
TUMOR BIOLOGY (2016)
Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer
Juntao Feng et al.
ONCOTARGETS AND THERAPY (2016)
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
Wen-Juan Huang et al.
ONCOLOGY LETTERS (2016)
Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
Xiao-Yang Dai et al.
ONCOTARGET (2016)
Repurposing metformin for cancer treatment: current clinical studies
Young Kwang Chae et al.
ONCOTARGET (2016)
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
Huabing Zhang et al.
SCIENCE SIGNALING (2015)
Disease implications of the Hippo/YAP pathway
Steven W. Plouffe et al.
TRENDS IN MOLECULAR MEDICINE (2015)
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
Lisha Xiang et al.
ONCOTARGET (2015)
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
Huabing Zhang et al.
SCIENCE SIGNALING (2015)
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Biao Ma et al.
NATURE CELL BIOLOGY (2015)
Hypoxic conditions differentially regulate TAZ and YAP in cancer cells
Libo Yan et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Katarzyna Brodowska et al.
EXPERIMENTAL EYE RESEARCH (2014)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
Lijuan Wang et al.
PLOS ONE (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth
Brent A. Orr et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
Yang Wang et al.
CANCER SCIENCE (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Yes-Associated Protein Is an Independent Prognostic Marker in Hepatocellular Carcinoma
Michelle Z. Xu et al.
CANCER (2009)
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
Jianmin Zhang et al.
NATURE CELL BIOLOGY (2009)
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
D. A. Tennant et al.
ONCOGENE (2009)
Thalidomide for treatment of multiple myeloma: 10 years later
Antonio Palumbo et al.
BLOOD (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
The N-terminal Transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1α and HIF-2α
Cheng-Jun Hu et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration
U Schmidt-Erfurth et al.
SURVEY OF OPHTHALMOLOGY (2000)
分享论文
